Queensland Drug-Driving Bill Raises Medical Cannabis Concerns
Queensland medical cannabis driving law may bring stronger penalties for drivers who test positive for THC. The pending bill has renewed debate about roadside detection, impairment, and prescribed use. CED explains what patients and clinicians should…
Detection of Δ9-Tetrahydrocannabinol Impairment Using Resting-State Functional Near-Infrared Spectroscopy: A Randomized Clinical Trial.
This randomized trial demonstrates that THC impairment detection via functional near-infrared spectroscopy is more accurate than field sobriety tests. The neuroimaging method offers an objective approach to cannabis impairment testing. These findings…
Appeal Dismissed in THC Impaired Driving Case Involving Child’s Death
The THC impaired driving legal case appeal was dismissed, reinforcing the complexities of cannabis impairment detection. THC blood levels do not reliably indicate impairment like alcohol. This case underscores the need for clear clinical guidance on…
Appeal Court Upholds Stay in THC-Impaired Driving Charge in Saskatoon
THC impaired driving legal challenges remain complex due to forensic limitations in measuring impairment. The Saskatchewan appeal court upheld a stay of charges in a fatal THC-impaired driving case. This highlights ongoing difficulties in using THC blood…
Understanding THC Impairment Testing Challenges in Clinical Practice
THC impairment testing challenges complicate clinical and legal assessments due to poor correlation between THC levels and functional impairment. Unlike alcohol, THC pharmacokinetics create variability in impairment detection. Understanding these…